Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the…
AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the US Food and Drug Administration…
Read More...
Read More...
